Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.23 Insider Own6.37% Shs Outstand11.67M Perf Week-7.46%
Market Cap36.18M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.93M Perf Month-16.89%
Income-16.46M PEG- EPS next Q- Inst Own1.42% Short Float2.40% Perf Quarter198.08%
Sales0.00M P/S- EPS this Y- Inst Trans-5.93% Short Ratio1.01 Perf Half Y740.11%
Book/sh-0.56 P/B- EPS next Y- ROA-69.38% Short Interest0.26M Perf Year195.24%
Cash/sh0.01 P/C602.95 EPS next 5Y- ROE-104.08% 52W Range0.22 - 5.26 Perf YTD458.56%
Dividend Est.- P/FCF- EPS past 5Y23.21% ROI-165.65% 52W High-41.06% Beta2.10
Dividend TTM- Quick Ratio0.15 Sales past 5Y-17.99% Gross Margin17.19% 52W Low1306.53% ATR (14)0.47
Dividend Ex-Date- Current Ratio0.15 EPS Y/Y TTM41.00% Oper. Margin0.00% RSI (14)42.62 Volatility9.65% 16.40%
Employees5 Debt/Eq0.38 Sales Y/Y TTM-100.00% Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.30 EPS Q/Q80.97% Payout- Rel Volume0.00 Prev Close3.10
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume259.20K Price3.10
SMA20-13.69% SMA50-7.97% SMA200127.68% Trades Volume0 Change0.00%
Today 06:45AM
May-28-24 02:00AM
May-16-24 04:00PM
May-13-24 07:30AM
04:10PM Loading…
May-10-24 04:10PM
May-03-24 10:52PM
Mar-15-24 09:00AM
Nov-09-23 08:05AM
Sep-21-23 11:30AM
Aug-31-23 01:30PM
Aug-29-23 01:30PM
Aug-25-23 02:30PM
Aug-22-23 05:30PM
07:00PM Loading…
Aug-18-23 07:00PM
Jun-28-23 08:30AM
Apr-18-23 08:30AM
Apr-13-23 08:30AM
Mar-24-23 10:55AM
Mar-23-23 08:30AM
Mar-22-23 08:30AM
Feb-22-23 08:30AM
Jan-26-23 08:30AM
Jan-10-23 08:30AM
Sep-16-22 09:46AM
Jul-05-22 09:00AM
09:00AM Loading…
Jun-28-22 09:00AM
Jun-09-22 08:30AM
Jun-08-22 07:07AM
Jun-07-22 08:30AM
May-31-22 09:00AM
Apr-07-22 06:31PM
Jan-25-22 09:38AM
Jan-21-22 09:38PM
Jan-04-22 09:00AM
Dec-16-21 09:00AM
Dec-07-21 09:00AM
Nov-08-21 06:58AM
Oct-27-21 09:00AM
Oct-19-21 09:00AM
Oct-12-21 09:00AM
Oct-07-21 09:00AM
Sep-30-21 09:00AM
Sep-28-21 04:05PM
Jul-22-21 09:45AM
Jun-23-21 10:10AM
Jun-22-21 09:46AM
Jun-15-21 10:15AM
Jun-10-21 10:15AM
Jun-08-21 09:45AM
Feb-25-21 09:29AM
Feb-02-21 11:45AM
Jan-29-21 08:45AM
Sep-24-20 10:45AM
Sep-22-20 09:45AM
Sep-16-20 02:37PM
Sep-03-20 10:30AM
Aug-31-20 05:00PM
Aug-28-20 02:34PM
Aug-26-20 09:45AM
Aug-21-20 10:31AM
Aug-19-20 02:50PM
Aug-11-20 07:00PM
Aug-06-20 02:30PM
Aug-04-20 09:47AM
Jul-30-20 09:30AM
Jul-21-20 09:25AM
Jul-08-20 09:30AM
Jun-30-20 09:30AM
Jun-25-20 02:23PM
Jun-18-20 09:27AM
Feb-06-20 09:02AM
Jan-28-20 09:02AM
Jan-23-20 09:02AM
Jan-16-20 10:51AM
Dec-03-19 09:03AM
Nov-25-19 09:00AM
Sep-12-19 08:00AM
Sep-11-19 08:03AM
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.